The Best Over-The-Counter Sleep Aids

The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia (HeFH). Image source: Merck.com.

Mega Doctor News CLEVELAND CLINIC - As electric bikes and scooters grow in...

If you like blueberries, or have been thinking about trying them, you may be surprised to know this tiny fruit offers some big health benefits.

The Society’s Clinical Practice Guideline on testosterone replacement therapy in men with hypogonadism offers recommendations on appropriate testing and prescribing practices.